thiophenes has been researched along with fibrinogen in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (62.50) | 18.7374 |
| 1990's | 1 (4.17) | 18.2507 |
| 2000's | 3 (12.50) | 29.6817 |
| 2010's | 5 (20.83) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boneu-Valmalette, A; Bugat, R; Combes, PF; David, JF | 1 |
| Lechner, H; Ott, E | 1 |
| Eda, T; Hidaka, Y; Kamei, T; Yonemoto, M | 1 |
| Horikoshi, S; Mitsuka, S; Miyagi, O; Nukui, H; Ohe, C; Sasaki, H; Shibasaki, T; Tamada, J; Toyoda, O | 1 |
| Cerbone, AM; Di Minno, G; Iovine, C; Mancini, M; Mattioli, PL; Turco, S | 1 |
| Battocchio, F; Crociani, ME; Fabris, F; Girolami, A; Randi, ML | 1 |
| Bennert, C; Berger, E; Jäger, W; Kauschmann, R; Kutschera, J; Pietsch, U; Riese, W; Wendeberg, H | 1 |
| Beller, FK; Slabber, CF; Theiss, W | 1 |
| Caen, JP; Dunn, FW; Lee, H; Soria, C; Soria, J; Thomaidis, A | 1 |
| Alessandri, C; Balsano, F; Frattaroli, S; Ghiselli, A; Violi, F | 1 |
| Carfagna, S; Carrieri, P; Fioretti, A; Indaco, A; Orefice, G | 1 |
| d'Avenia, V; di Minno, G; Iovine, C; Mattioli, PL; Turco, S | 1 |
| Caen, JP; Lee, H; Paton, RC; Ruan, C | 1 |
| Furukawa, Y; Kondo, M; Murakami, M; Takemura, S; Yoshikawa, T | 1 |
| Bousser, MG; Conard, J; Horellou, MH; Lecrubier, C; Samama, M; Scarabin, PY | 1 |
| Abiko, Y; Ashida, S; Sakuma, K | 1 |
| Asai, F; Iwamura, R; Koike, H; Ogawa, T; Otsuguro, K; Sugidachi, A; Yoneda, K | 1 |
| Germann, PG; Häfner, D; Ibrahim, M; Wollin, L | 1 |
| Hatzizacharias, A; Krespi, P; Makris, TK; Papadopoulos, DP; Stavroulakis, G; Tsoukala, C; Votteas, VE; Zilidis, A | 1 |
| Baghaei, F; Fagerberg Blixter, I; Gustafsson, KM; Hillarp, A; Lindahl, TL; Sten-Linder, M; Stigendal, L; Strandberg, K | 1 |
| Hesse, C; Lindhoff-Last, E; Mani, H; Stratmann, G | 1 |
| Guan, Z; Kou, B; Li, H; Lin, J; Wei, W; Zhang, H; Zhou, D | 1 |
| Bailleul, E; Chatelain, B; Coucke, W; Demulder, A; Devreese, K; Douxfils, J; Jochmans, K; Mullier, F; Soumali, MR; Van Blerk, M; Van de Walle, P; Vernelen, K; Wijns, W | 1 |
| Amsallem, M; Bal dit Sollier, C; Dillinger, JG; Drouet, L; Henry, P; Manzo-Silberman, S; Sideris, G; Voicu, S | 1 |
5 trial(s) available for thiophenes and fibrinogen
| Article | Year |
|---|---|
[The influence of tinofedrine on fibrinogen and platelet aggregation in patients with recent cerebral infarction (author's transl)].
Topics: Aged; Benzyl Alcohols; Benzyl Compounds; Cerebral Infarction; Cerebrovascular Circulation; Female; Fibrinogen; Humans; Male; Middle Aged; Platelet Aggregation; Thiophenes | 1978 |
Effects of ticlopidine on blood fibrinogen and blood viscosity in peripheral atherosclerotic disease.
Topics: Aged; Arteriosclerosis; Blood Coagulation; Blood Platelets; Blood Viscosity; Female; Fibrinogen; Humans; Locomotion; Male; Middle Aged; Nicotinic Acids; Thiophenes; Ticlopidine | 1985 |
Effects of ticlopidine on platelet function and blood coagulation.
Topics: Adult; Aged; Arteriosclerosis; beta-Thromboglobulin; Blood Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Malondialdehyde; Middle Aged; Partial Thromboplastin Time; Platelet Aggregation; Platelet Function Tests; Prothrombin Time; Thiophenes; Ticlopidine | 1982 |
Eprosartan effect on fibrinolytic/hemostatic variables in arterial hypertension: a comparative study to losartan.
Topics: Acrylates; Aged; Angiotensin II Type 1 Receptor Blockers; Drug Administration Schedule; Female; Fibrinogen; Fibrinolysis; Follow-Up Studies; Hemostasis; Humans; Hypertension; Imidazoles; Lipoproteins; Losartan; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Receptor, Angiotensin, Type 1; Thiophenes; Thrombomodulin; Time Factors; Tissue Plasminogen Activator | 2004 |
[Effects of thromboprophylaxis duration on coagulation indicators after total hip replacement].
Topics: Adult; Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Blood Coagulation Tests; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Morpholines; Peptide Fragments; Prothrombin; Rivaroxaban; Thiophenes | 2014 |
19 other study(ies) available for thiophenes and fibrinogen
| Article | Year |
|---|---|
[Kinetics of I-131 fibrinogen in cancer patients: pharmacological approach].
Topics: Aspirin; Blood Coagulation; Fibrinogen; Fibrinolytic Agents; Heparin; Indomethacin; Iodine Radioisotopes; Kinetics; Neoplasms; Platelet Aggregation; Prednisone; Pyridines; Thiophenes | 1977 |
Inhibition of cultured vascular smooth muscle cell migration by simvastatin (MK-733).
Topics: Animals; Anticholesteremic Agents; Aorta, Thoracic; Benzylamines; Cell Movement; Cells, Cultured; Dose-Response Relationship, Drug; Fibrinogen; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Lovastatin; Mevalonic Acid; Muscle, Smooth, Vascular; Nifedipine; Platelet-Derived Growth Factor; Pravastatin; Simvastatin; Sterols; Swine; Thiophenes | 1992 |
[Changes of blood coagulability and effects of the platelet aggregation inhibitor (ticlopidine) in experimental subarachnoid hemorrhage in dogs].
Topics: Animals; Anticoagulants; Basilar Artery; Blood Coagulation; Dogs; Fibrinogen; Platelet Aggregation; Subarachnoid Hemorrhage; Thiophenes; Ticlopidine | 1985 |
Functionally thrombasthenic state in normal platelets following the administration of ticlopidine.
Topics: Adenosine Triphosphate; Adult; Animals; Bleeding Time; Blood Platelet Disorders; Blood Platelets; Clot Retraction; Female; Fibrinogen; Glycoproteins; Humans; In Vitro Techniques; Male; Membrane Proteins; Platelet Aggregation; Platelet Membrane Glycoproteins; Rats; Thiophenes; Ticlopidine; von Willebrand Factor | 1985 |
[The continuous measurement of platelet aggregation without the addition of aggregation inducers. II. Experimental results and testing of aggregation inducers].
Topics: Aspirin; Benzyl Compounds; Cycloheptanes; Dimethylamines; Ethanolamines; Fibrinogen; Humans; In Vitro Techniques; Morpholines; Photometry; Piperazines; Piperidines; Platelet Adhesiveness; Platelet Aggregation; Polysaccharides; Pyrimidines; Sulfuric Acids; Thiophenes | 1974 |
The prevention of endotoxin-induced glomerular fibrin deposition by pyrimido-pyrimidine compounds.
Topics: Animals; Aspirin; Blood Cell Count; Blood Platelets; Disseminated Intravascular Coagulation; Endotoxins; Escherichia coli; Female; Fibrin; Fibrinogen; Injections, Intravenous; Kidney Glomerulus; Microcirculation; Morpholines; Pyrimidines; Rabbits; Thiophenes | 1972 |
In vivo effect of ticlopidine on fibrinogen-platelet cofactor activity and binding of fibrinogen to platelets.
Topics: Adenosine Diphosphate; Anticoagulants; Blood Platelets; Fibrinogen; Humans; In Vitro Techniques; Platelet Aggregation; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Thiophenes; Ticlopidine | 1984 |
Effects of long-term ticlopidine treatment on platelet function and its tolerability in cerebrovascular disease.
Topics: Adult; Aged; Anticoagulants; Blood Coagulation Tests; Blood Platelets; Cerebrovascular Disorders; Female; Fibrinogen; Humans; Ischemic Attack, Transient; Male; Middle Aged; Platelet Adhesiveness; Platelet Aggregation; Thiophenes; Ticlopidine; Time Factors | 1984 |
Ex vivo effects of ticlopidine on human platelets: inhibition of fibrinogen binding by a mechanism independent of thromboxane formation.
Topics: Anticoagulants; Blood Platelets; Fibrinogen; Humans; Platelet Aggregation; Thiophenes; Thromboxanes; Ticlopidine | 1984 |
The in vitro effect of ticlopidine on fibrinogen and factor VIII binding to human platelets.
Topics: Anticoagulants; Blood Platelets; Cells, Cultured; Depression, Chemical; Factor VIII; Fibrinogen; Humans; In Vitro Techniques; Platelet Aggregation; Pyridines; Thiophenes; Ticlopidine | 1981 |
Effects of ticlopidine and aspirin on endotoxin-induced disseminated intravascular coagulation in rats.
Topics: Animals; Aspirin; Disease Models, Animal; Disseminated Intravascular Coagulation; Endotoxins; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Kidney Glomerulus; Partial Thromboplastin Time; Platelet Count; Prothrombin Time; Rats; Rats, Inbred Strains; Thiophenes; Ticlopidine | 1983 |
Effects of long term administration of ticlopidine on platelet function and hemostatic variables.
Topics: Adult; Afibrinogenemia; Aged; Antithrombin III; Bleeding Time; Blood Platelets; Blood Sedimentation; Female; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Platelet Aggregation; Pyridines; Thiophenes; Ticlopidine; Time Factors | 1980 |
Antithrombotic effects of ticlopidine, acetylsalicyclic acid and dipyridamole in vascular shunt model in rats.
Topics: Animals; Arteriovenous Shunt, Surgical; Aspirin; Blood Coagulation; Blood Coagulation Tests; Dipyridamole; Fibrinogen; Fibrinolytic Agents; Hematocrit; Male; Platelet Aggregation; Platelet Count; Pyridines; Rats; Serum Globulins; Thiophenes; Ticlopidine | 1980 |
Antiplatelet action of R-99224, an active metabolite of a novel thienopyridine-type G(i)-linked P2T antagonist, CS-747.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Calcium; Cyclic AMP; Cyclopropanes; Fibrinogen; GTP-Binding Protein alpha Subunits, Gi-Go; Humans; In Vitro Techniques; Male; Membrane Proteins; Piperazines; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Thionucleotides; Thiophenes | 2001 |
Cyclooxygenase-inhibition enhances the effects of rSP-C surfactant therapy in a rat lavage model of acute respiratory distress syndrome (ARDS).
Topics: Acute Disease; Aniline Compounds; Animals; Blood Gas Analysis; Bronchoalveolar Lavage; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Fibrinogen; Injections, Intravenous; Intubation, Intratracheal; Lung; Male; Microscopy, Confocal; Pulmonary Surfactants; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Respiratory Distress Syndrome; Thiophenes | 2003 |
Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays.
Topics: Activated Protein C Resistance; Administration, Oral; Adult; Anticoagulants; Antithrombins; Blood Coagulation; Blood Coagulation Tests; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Female; Fibrinogen; Humans; Male; Morpholines; Partial Thromboplastin Time; Predictive Value of Tests; Prothrombin Time; Reproducibility of Results; Rivaroxaban; Thiophenes | 2011 |
Rivaroxaban differentially influences ex vivo global coagulation assays based on the administration time.
Topics: Aged; Anticoagulants; Antithrombins; Blood Coagulation; Blood Coagulation Tests; Clinical Protocols; Drug Interactions; Factor Xa Inhibitors; Female; Fibrinogen; Humans; Male; Middle Aged; Morpholines; Orthopedic Procedures; Postoperative Complications; Rivaroxaban; Thiophenes; Time Factors; Venous Thromboembolism | 2011 |
Influence of dabigatran and rivaroxaban on routine coagulation assays. A nationwide Belgian survey.
Topics: Administration, Oral; Anticoagulants; Antithrombins; Belgium; Benzimidazoles; beta-Alanine; Biomarkers; Blood Coagulation; Dabigatran; Dose-Response Relationship, Drug; Equipment Design; Fibrinogen; Health Care Surveys; Humans; Laboratory Proficiency Testing; Morpholines; Observer Variation; Partial Thromboplastin Time; Predictive Value of Tests; Prothrombin Time; Quality Indicators, Health Care; Reproducibility of Results; Rivaroxaban; Thiophenes; Time Factors | 2015 |
Predictors of high on-aspirin platelet reactivity in high-risk vascular patients treated with single or dual antiplatelet therapy.
Topics: Adenosine; Aged; Aspirin; Cerebrovascular Disorders; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Female; Fibrinogen; Humans; Male; Middle Aged; Piperazines; Platelet Activation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Predictive Value of Tests; Purinergic P2Y Receptor Antagonists; Retrospective Studies; Secondary Prevention; Thiophenes; Ticagrelor; Ticlopidine | 2015 |